Director, Commercial Strategy and Business Development Assessment

Director, Commercial Strategy And Business Development Assessment

Statistics show that women and underrepresented groups tend to apply to jobs only if they meet 100% of the qualifications. Sobi encourages you to change that statistic and apply. Rarely do candidates meet 100% of the qualifications. We look forward to your application!

At Sobi, each person brings their unique talents to work as a team and make a difference. We are dedicated to developing and delivering innovative therapies to improve the lives of people who live with a rare disease. Our edge comes from our team of people and our commitment to patients.

Our mission and culture at Sobi North America get us excited to come to work every day, but here are a few more reasons to join our team:

• Competitive compensation for your work
• Generous time off policy
• Summer Fridays
• Opportunity to broaden your horizons by attending popular conferences
• Emphasis on work/life balance
• Collaborative and team-oriented environment
• Making a positive impact to help ultra-rare disease patients who are in need of life saving treatments

The Director, Commercial Strategy & Business Development Assessment is responsible for supporting U.S. commercial assessments, commercialization planning, strategic evaluations, policy assessments, and integration planning activities for external business development opportunities and internal portfolio expansion initiatives. This role serves as a key commercial assessment partner for evaluating acquisition, licensing, partnership, and portfolio investment opportunities by assessing market attractiveness, patient opportunity, pricing potential, reimbursement feasibility, commercialization requirements, operating model design, competitive dynamics, and long-term value creation potential.

This role bridges commercial strategy, commercialization planning, market access, pricing, business development assessment, portfolio evaluation, policy assessment, and integration planning to support informed investment decisions and long-term portfolio growth. In addition, this role supports Market Access policy initiatives and post-acquisition integration planning by partnering with Market Access leadership, Business Development, and the central integration team to ensure successful evaluation, planning, and execution of new opportunities.

DUTIES & RESPONSIBILITIES

Strategic Leadership & Portfolio Assessment

• Lead U.S. commercial assessments for acquisition, licensing, partnership and strategic business development opportunities.

• Evaluate strategic fit, unmet need, treatment paradigms, competitive intensity, market attractiveness and long-term commercial potential.

• Support internal portfolio strategy initiatives including new indications, lifecycle management opportunities, reformulations and line extensions.

• Develop recommendations regarding commercial viability, launch feasibility, investment requirements, organizational implications and key risks.

• Assess alignment with corporate strategy and long-term growth objectives.

Commercial Due Diligence & Market Opportunity Assessment

• Lead commercial due diligence activities.

• Assess epidemiology, diagnosed populations, treated populations, addressable patient populations, treatment algorithms and site-of-care dynamics.

• Develop market sizing methodologies and opportunity assessments

• Conduct primary and secondary research to validate assumptions.

• Partner with Business Analytics to validate epidemiology, patient opportunity and forecast inputs.

• Evaluate competitive landscapes, pipeline threats and future market evolution.

• Participate actively in diligence meetings with target companies and consultants.

Pricing, Reimbursement & Market Access Strategy

• Develop pricing recommendations and commercial pricing frameworks.

• Evaluate pricing potential relative to clinical differentiation and payer expectations.

• Develop gross-to-net assumptions and reimbursement frameworks.

• Assess Medicare, Medicaid, Commercial, Specialty Pharmacy and Buy-and-Bill reimbursement implications.

• Evaluate payer management expectations, utilization management risks and access barriers.

• Assess coding, payment,…